Evidence map›Paper›PMID 36091016›Full record

ArticleFrontiers in immunology2022

Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies.

Abigail E Powell, Duo Xu, Gillie A Roth, Kaiming Zhang, Wah Chiu, Eric A Appel, Peter S Kim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Design of universal Ebola virus vaccine candidates via immunofocusing.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Design of universal Ebola virus vaccine candidatesbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Abigail E PowellDepartment of Biochemistry and Stanford ChEM-H, Stanford University, Stanford, CA, United States.
Duo XuDepartment of Biochemistry and Stanford ChEM-H, Stanford University, Stanford, CA, United States.
Gillie A RothDepartment of Bioengineering, Stanford University, Stanford, CA, United States.
Kaiming ZhangDepartment of Bioengineering, Stanford University, Stanford, CA, United States.
Wah ChiuDepartment of Bioengineering, Stanford University, Stanford, CA, United States.
Eric A AppelDepartment of Bioengineering, Stanford University, Stanford, CA, United States.
Peter S KimDepartment of Biochemistry and Stanford ChEM-H, Stanford University, Stanford, CA, United States.
Stanford University · US

Funding

Creating high-resolution, epitope-focused vaccinesDP1AI158125 · NIAID · STANFORD UNIVERSITY · PI KIM, PETER S · 2020 to 2024
$5.9M
NIAID NIH HHS DP1 AI158125
6 · The paper itself

Abstract

Ebola virus (EBOV), a member of the

Indexed as

Ebola VaccinesEbolavirusHemorrhagic Fever, EbolaNanoparticlesAnimalsAntibodies, NeutralizingAntibodies, ViralMiceAntibodies, NeutralizingAntibodies, ViralEbola VaccinesebolavirusglycoproteinGPΔmucinprotein nanoparticlessubunit vaccine

Identifiers

PMID36091016
PMCPMC9449635
OpenAlexW4293171025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.